Check out your Company Bowl for anonymous work chats.
Verily is hiring across several businesses, with many positions remote. As an Alphabet company, we offer extensive benefits, perks, and competitive compensation. Explore jobs: https://bit.ly/3SYG4wm
In an interview with pharmaphorum, our Head of Molecular Science Charlie Kim spoke about the latest breakthrough in Verily's collaborative research effort with Sosei Heptares, including our human-first precision approach to drug target discovery. "Immune-mediated diseases are highly complex and, oftentimes, therapies that work for one patient may not be effective for another. Precision health seeks to create the greatest number of options possible, as well as make sure every patient has the most targeted treatment for their condition, physiology, and more." – Charlie Kim Read the article for more.
Now is the time to join Verily! "Alphabet's Verily raises $1 bln in funding round"
The Project Baseline Health study just published a new paper in Journal of Affective Disorders that looks at the complex associations between socioeconomic factors and anxiety. The findings show the importance of taking a whole person approach when diagnosing and treating anxiety. Congrats to the authors, contributing teams, and the 2.5K+ study participants on this important effort to advance the field and improve health for all! #SocialDeterminantsOfHealth #SDoH #anxiety
The latest coming out of Verily! Leveraging high-resolution multi-omic data and sophisticated analytics, together with Sosei Heptares we were able to prioritize and advance high-confidence GPCR targets into target validation in just six months. Learn how our Immune Profiler platform’s human-first precision approach to drug discovery can accelerate and enhance drug development.
We are continuing our big moves at Verily. Read about our recent work with Google Health developing an AI to recognize different phases of complex LC surgeries (gallbladder removal). Explore our open roles in this important work to help make surgeries safer for all.
Did you know Verily was the first to track monkeypox in waste water? Fortune covered Verily's current research on monkeypox and how we're working to detect it. "Using the same setup and even samples it was using to test for COVID-19 and subvariants, RSV, and flu, Verily was able to quickly pivot and add testing for monkeypox. It will soon add a test that determines which variants of monkeypox are appearing in local sewer systems and may add an assay for polio, if staff at local public health agencies ask for it, Boehm said." “It’s the future, and a resource we haven’t yet taken full advantage of.”
We're honored to be ranked among The Healthcare Technology Report's Top 100 Healthcare Technology Companies of 2022. Verily was described as “dedicated to using the power of data to change how healthcare is managed and delivered.” Join us in this important work. Explore roles here: verily.com/careers #BuildWhatsVital #HealthTech #HealthcareInnovation #healthcare
Have you ever participated in a health study? Verily's Project Baseline Health Study just celebrated its four-year anniversary! Through the efforts of participants and researchers from the California Health & Longevity Institute, Inc, Stanford Medicine, and Duke University School of Medicine, they have 19 total research publications, spanning across mental health, heart health, and COVID-19. Join us in this life-changing work! Explore opportunities here: https://verily.com/careers/ Click to hear thoughts from our participants: https://bit.ly/3Oy5ZbG
Watch now! Fortune On Demand: featuring Verily founder Jessica Mega on how technology will continue to change healthcare in the aftermath of the pandemic. One of the biggest advances is the work Verily is doing around precision health - the integration of clinical and non-clinical data, and harnessing insights that are relevant to the individual. Click to watch!
